Low Molecular Weight Heparin (LMWH)

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi is a publicly-traded Spanish pharmaceutical company with a mission to develop, manufacture, and commercialize innovative therapies, particularly in biosimilars and low molecular weight heparins. The company has achieved significant scale through its dual business model, combining a profitable specialty pharma division with a strategic CDMO arm that serves third-party clients. Its strategy focuses on R&D investment in biosimilars as a core growth engine, while expanding its international commercial footprint and manufacturing capabilities to capitalize on high-value market opportunities.

Therapeutic Areas